07:00 , Nov 1, 2010 |  BioCentury  |  Finance

Specialty Pearl

Specialty Pearl Specialty pharma-focused venture firm Vatera Healthcare Partners invested in its fourth portfolio company last month, leading a $69 million series C round for respiratory disease company Pearl Therapeutics Inc. Vatera was formed in...